Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Verona Pharma PLC ADR (VRNA) stocks

Learn how to easily invest in Verona Pharma PLC ADR stocks.

Verona Pharma PLC ADR is a biotechnology business based in the US. Verona Pharma PLC ADR stocks (VRNA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.86 – an increase of 6.92% over the previous week. Verona Pharma PLC ADR employs 24 staff and has a trailing 12-month revenue of around $40 million.

How to buy stocks in Verona Pharma PLC ADR

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VRNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Verona Pharma PLC ADR stock price (NASDAQ:VRNA)

Use our graph to track the performance of VRNA stocks over time.

Verona Pharma PLC ADR shares at a glance

Information last updated 2022-06-23.
Latest market close$4.48
52-week range$3.41 - $7.25
50-day moving average $4.19
200-day moving average $5.13
Wall St. target price$19.83
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.99

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$0 if conditions met, otherwise $100 a year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Scotia iTRADE
Finder Rating:
3.8 / 5
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Finder Rating:
3.9 / 5
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Verona Pharma PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Verona Pharma PLC ADR price performance over time

Historical closes compared with the close of $4.48 from 2022-06-24

1 week (2022-06-17) 6.92%
1 month (2022-05-27) 4.48
3 months (2022-03-28) -10.58%
6 months (2021-12-28) -36.27%
1 year (2021-06-28) -33.13%
2 years (2020-06-26) -11.46%
3 years (2019-06-28) 5.1
5 years (2017-06-27) 12.0697

Verona Pharma PLC ADR financials

Revenue TTM $40 million
Gross profit TTM $40 million
Return on assets TTM -21.09%
Return on equity TTM -39.58%
Profit margin -147.79%
Book value $2.09
Market capitalisation $266.8 million

TTM: trailing 12 months

Verona Pharma PLC ADR share dividends

We're not expecting Verona Pharma PLC ADR to pay a dividend over the next 12 months.

Verona Pharma PLC ADR share price volatility

Over the last 12 months, Verona Pharma PLC ADR's shares have ranged in value from as little as $3.408 up to $7.25. A popular way to gauge a stock's volatility is its "beta".

VRNA.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma PLC ADR's is 0.6661. This would suggest that Verona Pharma PLC ADR's shares are less volatile than average (for this exchange).

Verona Pharma PLC ADR overview

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site